Beyond its role in development, IGFBP5 has been investigated in pathologies such as idiopathic pulmonary fibrosis (IPF) (49), liver disease (50), obesity (51), and the negative impacts of aging (52). This evidence concerns the gene IGFBP5 and liver disorder.